GINA BURBANK: Open Payments
NPI 1255808754 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 41 payments from 21 companies in 2025. Trend: 2023 $640 · 2024 $774 · 2025 $976
Food & beverage: $901Education: $75
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $213 |
| Novartis Pharmaceuticals Corporation | 6 | $167 |
| AstraZeneca Pharmaceuticals LP | 2 | $72 |
| Stemline Therapeutics Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $46 |
| TAIHO ONCOLOGY, INC. | 1 | $32 |
| PharmaEssentia USA Corporation | 1 | $28 |
Products named: KISQALI, Enhertu, IBRANCE, Orserdu, KEYTRUDA, DARZALEX, Venclexta, LONSURF.
Industry payments across GA — which companies pay providers there.
